-transparent.png){kind=logo}
The tricyclic antidepressant drug amitriptyline was evaluated as a short-term treatment of anorexia nervosa patients. In a 5-week double-blind, placebo-controlled study 11 patients were given amitriptyline and 14 received placebo. In addition, 18 patients who refused to participate in the drug trial and received only psychosocial treatment were used as an additional comparison group. Overall, patients in the three groups showed little improvement. No statistically significant differences favoring amitriptyline were found in any of the outcome variables. Plasma levels varied widely among patients receiving similar doses. No association was found between plasma levels and improvement in either psychiatric symptomatology or weight. Amitriptyline patients did not manifest any tendency for a reduction of depressive symptomatology. In addition, amitriptyline treatment was associated with substantial discomfort and adverse affects.
J Biederman, and
D B Herzog, and
T M Rivinus, and
G P Harper, and
R A Ferber, and
J F Rosenbaum, and
J S Harmatz, and
R Tondorf, and
P J Orsulak, and
J J Schildkraut
July 2012,
European eating disorders review : the journal of the Eating Disorders Association,
J Biederman, and
D B Herzog, and
T M Rivinus, and
G P Harper, and
R A Ferber, and
J F Rosenbaum, and
J S Harmatz, and
R Tondorf, and
P J Orsulak, and
J J Schildkraut
March 1984,
The British journal of psychiatry : the journal of mental science,
J Biederman, and
D B Herzog, and
T M Rivinus, and
G P Harper, and
R A Ferber, and
J F Rosenbaum, and
J S Harmatz, and
R Tondorf, and
P J Orsulak, and
J J Schildkraut
June 2005,
The Journal of clinical endocrinology and metabolism,
J Biederman, and
D B Herzog, and
T M Rivinus, and
G P Harper, and
R A Ferber, and
J F Rosenbaum, and
J S Harmatz, and
R Tondorf, and
P J Orsulak, and
J J Schildkraut
October 2008,
The American journal of psychiatry,
J Biederman, and
D B Herzog, and
T M Rivinus, and
G P Harper, and
R A Ferber, and
J F Rosenbaum, and
J S Harmatz, and
R Tondorf, and
P J Orsulak, and
J J Schildkraut
May 1986,
Arthritis and rheumatism,
J Biederman, and
D B Herzog, and
T M Rivinus, and
G P Harper, and
R A Ferber, and
J F Rosenbaum, and
J S Harmatz, and
R Tondorf, and
P J Orsulak, and
J J Schildkraut
September 2011,
Journal of the American Academy of Child and Adolescent Psychiatry,
J Biederman, and
D B Herzog, and
T M Rivinus, and
G P Harper, and
R A Ferber, and
J F Rosenbaum, and
J S Harmatz, and
R Tondorf, and
P J Orsulak, and
J J Schildkraut
December 1982,
Acta psychiatrica Scandinavica,
J Biederman, and
D B Herzog, and
T M Rivinus, and
G P Harper, and
R A Ferber, and
J F Rosenbaum, and
J S Harmatz, and
R Tondorf, and
P J Orsulak, and
J J Schildkraut
August 1984,
Journal of clinical psychopharmacology,
J Biederman, and
D B Herzog, and
T M Rivinus, and
G P Harper, and
R A Ferber, and
J F Rosenbaum, and
J S Harmatz, and
R Tondorf, and
P J Orsulak, and
J J Schildkraut
March 1998,
International clinical psychopharmacology,
J Biederman, and
D B Herzog, and
T M Rivinus, and
G P Harper, and
R A Ferber, and
J F Rosenbaum, and
J S Harmatz, and
R Tondorf, and
P J Orsulak, and
J J Schildkraut
February 1996,
Psychiatry research,
